Download Free Who Costing And Budgeting Tool For National Action Plans On Antimicrobial Resistance Book in PDF and EPUB Free Download. You can read online Who Costing And Budgeting Tool For National Action Plans On Antimicrobial Resistance and write the review.

In 2015 the World Health Assembly endorsed the Global action plan on antimicrobial resistance calling on countries to develop and implement national action plans on antimicrobial resistance (AMR). For most countries, the greatest challenge is not developing a national action plan; rather, it is the implementation of the plan based on evidence-based prioritization of activities, systematic monitoring of progress, and ensuring sustainability of efforts. The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plan on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action plan activities. The target audience of the publication are national/subnational stakeholders working on AMR within the human health sector. This includes national health authorities, national multisectoral coordination groups, senior technical experts and policymakers involved in implementing AMR activities at all levels of the health system, and implementation partners to accelerate sustainable implementation and monitoring and evaluation of national action plans on AMR.
The second meeting of the Strategic and Technical Advisory Group for Antimicrobial Resistance (STAG-AMR) was held in Geneva, 14-16 June 2022. This report provides a summary of the discussions and includes the specific observations and recommendations made by members of the STAG-AMR to WHO on the items under discussion.
This is the 2024 update of the Compendium of WHO and other UN guidance on health and environment. The Compendium is a comprehensive collection of available WHO and other UN guidance for improving health by creating healthier environments. It provides an overview and easy access of more than 500 actions, and a framework for thinking about health and environment interventions. It covers a broad range of areas such as air pollution, water, sanitation and hygiene, climate change, chemicals, radiation, or food systems. Guidance is classified according to principal sectors involved, level of implementation (national, community, health care), the type of instrument (taxes, infrastructure etc.) and the category of evidence. The Compendium compiles existing guidance from hundreds of documents in a simple and systematized format. To ensure the most up-to-date information is provided to the end users, the Compendium is updated on a regular basis and incorporates the latest major WHO or other UN guidance on health and environment. The target audience includes any decision-makers with relevance to health and environment, and those assisting them (such as mayors, staff in ministries, UN country staff etc.). The Compendium has been prepared by WHO in cooperation with UN Environment, UNDP and UNICEF.
The primary objective of this curriculum is to equip health and care workers with the essential knowledge and competencies necessary for delivering safe and effective care. By doing so it aims to significantly reduce HAIs and combat antimicrobial resistance, thereby safeguarding both patient and HCWs well-being. This curriculum is developed to meet the needs of IPC professionals responsible for developing learning resources and overseeing training within health care organizations. Moreover, the curriculum is intended to encompass all individuals involved in health care delivery and support. This holistic approach includes a wide range of staff -ranging from clinical workers to administrative and auxiliary services, thus ensuring a broad and inclusive approach to IPC training. The guide is designed to be flexible, allowing for adaptation to various educational and practical contexts to meet specific national and local IPC requirements and policies. It delineates three distinct competency levels within the curriculum: • foundational: introduces basic IPC principles applicable universally across all health and care worker roles; • intermediate: delivers more detailed IPC practices, particularly for clinical practitioners in direct contact with patients; • advanced: provides specialized IPC knowledge tailored for clinical specialists and managerial roles, reflecting the specific needs of their positions and settings. This curriculum serves as an essential reference tool to support the planning, development, and localization of IPC education materials, aligning closely with the WHO core components for IPC programmes and the directions provided within the WHO global strategy and action plan on IPC. It supports countries in their efforts to implement actions to improve IPC knowledge and skills among health and care workers according to the recommendations in the WHO global action plan and monitoring framework. By enhancing the IPC competencies of health and care workers, this guide supports the capacity of the health care system to effectively manage and prevent infections, which is particularly crucial in improving patient outcomes and promoting safer health care environments, including in the context of epidemics, pandemics and other public health emergencies.
Health care-associated infections (HAI) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. At any one time, up to 7% of patients in developed and 10% in developing countries will acquire at least one HAI. These infections also present a significant economic burden at the societal level. However, a large percentage are preventable through effective infection prevention and control (IPC) measures. These new guidelines on the core components of IPC programmes at the national and facility level will enhance the capacity of Member States to develop and implement effective technical and behaviour modifying interventions. They form a key part of WHO strategies to prevent current and future threats from infectious diseases such as Ebola, strengthen health service resilience, help combat antimicrobial resistance (AMR) and improve the overall quality of health care delivery. They are also intended to support countries in the development of their own national protocols for IPC and AMR action plans and to support health care facilities as they develop or strengthen their own approaches to IPC. These are the first international evidence-based guidelines on the core components of IPC programmes. These new WHO guidelines are applicable for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The Joint External Evaluation (JEE) is a voluntary component of the International Health Regulations Monitoring and Evaluation Framework (IHRMEF). The JEE was introduced in 2016 to measure the availability of a country’s capacity to prevent, detect, and rapidly respond to public health emergencies. This third edition of the JEE includes improvements to the overall tool and new indicators based on the lessons learnt from the COVID19 pandemic. The third version of the JEE tool comprises of 19 technical areas and 56 indicators.
The National Strategy for Combating Antibiotic Resistant Bacteria, published in 2014, sets out a plan for government work to mitigate the emergence and spread of resistant bacteria. Direction on the implementation of this strategy is provided in five-year national action plans, the first covering 2015 to 2020, and the second covering 2020 to 2025. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine evaluates progress made against the national strategy. This report discusses ways to improve detection of resistant infections and estimate the risk to human health from environmental sources of resistance. In addition, the report considers the effect of agricultural practices on human and animal health and animal welfare and ways these practices could be improved, and advises on key drugs and diseases for which animal-specific test breakpoints are needed.